Literature DB >> 24140080

Evidence of sexual dimorphism in the placental function with severe preeclampsia.

S Muralimanoharan1, A Maloyan, L Myatt.   

Abstract

Preeclampsia (PE) affects 5-8% of pregnancies and is responsible for 18% of maternal deaths in the US, and for long-term complications in mother and child. PE is an inflammatory state and may influence placental function in a sex-specific manner. We determined if there is a sexual dimorphism in the placental inflammatory and apoptotic responses in preeclamptic pregnancies. Placentas were collected from normotensive and preeclamptic pregnancies with either male or female fetuses (MPE and FPE respectively) after c-section at term with no labor. Expression patterns of markers of inflammation measured by ELISA, as well as hypoxia, apoptosis and angiogenesis markers measured by Western blotting were determined in the placenta. Consistent with previous studies, an increase in inflammation, hypoxia, and apoptotic cell death was observed in PE compared to normotensive pregnancies. Levels of TNFα, IL-6 and IL-8, and HIF-1α were significantly greater, whereas the angiogenic marker VEGF was significantly reduced in MPE vs. FPE. Sexual dimorphism was also observed in the activation of cell death: the number of TUNEL-positive cells, and the expression pro-apoptotic markers PUMA and Bax being higher in MPE vs. FPE. We also found an increase in the levels of protein and DNA-binding activity of NFκB p65 in MPE vs. FPE. In summary, we show here that in preeclamptic pregnancies the placentas of males were associated with significantly higher expression of inflammatory, hypoxia and apoptotic molecules but reduced expression of a pro-angiogenic marker compared to placentas of female fetuses. We propose that the transcription factor NFκB p65 might, at least partially, be involved in sexual dimorphism during PE.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; BMI; HIF-1α; IL-6; IL-8; Inflammation; NFκB; NFκB p65; PE; PUMA; Preeclampsia; Sexual dimorphism; TNFα; VEGF; body mass index; hypoxia inducible factor-1alpha; interleukin 6; interleukin-8; nuclear factor kappa B; p53 upregulated modulator of apoptosis; preeclampsia; tumor necrosis factor alpha; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 24140080      PMCID: PMC3868439          DOI: 10.1016/j.placenta.2013.09.015

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  44 in total

1.  Placental apoptosis in preeclampsia.

Authors:  A D Allaire; K A Ballenger; S R Wells; M J McMahon; B A Lessey
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

2.  Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation.

Authors:  Naonori Ishihara; Hiroya Matsuo; Homare Murakoshi; Jovelle B Laoag-Fernandez; Takashi Samoto; Takeshi Maruo
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

Review 3.  NF-kappaB at the crossroads of life and death.

Authors:  Michael Karin; Anning Lin
Journal:  Nat Immunol       Date:  2002-03       Impact factor: 25.606

4.  Offspring sex and pregnancy outcome by length of gestation.

Authors:  Lars J Vatten; Rolv Skjaerven
Journal:  Early Hum Dev       Date:  2004-01       Impact factor: 2.079

Review 5.  Redefining preeclampsia using placenta-derived biomarkers.

Authors:  Anne Cathrine Staff; Samantha J Benton; Peter von Dadelszen; James M Roberts; Robert N Taylor; Robert W Powers; D Stephen Charnock-Jones; Christopher W G Redman
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

6.  Expression of inflammatory cytokines in placentas from women with preeclampsia.

Authors:  D F Benyo; A Smarason; C W Redman; C Sims; K P Conrad
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

7.  Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor.

Authors:  R Levy; S D Smith; K Chandler; Y Sadovsky; D M Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2000-05       Impact factor: 4.249

8.  Expression of nuclear factor-kappa B and placental apoptosis in pregnancies complicated with intrauterine growth restriction and preeclampsia: an immunohistochemical study.

Authors:  Meral Aban; Leyla Cinel; Murat Arslan; Umut Dilek; Mustafa Kaplanoglu; Rabia Arpaci; Saffet Dilek
Journal:  Tohoku J Exp Med       Date:  2004-11       Impact factor: 1.848

9.  Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex.

Authors:  Johan Arnt Steier; Magnar Ulstein; Ole L Myking
Journal:  Obstet Gynecol       Date:  2002-09       Impact factor: 7.661

10.  Effect of oxygen levels in villous trophoblast apoptosis.

Authors:  R T Kilani; M Mackova; S T Davidge; L J Guilbert
Journal:  Placenta       Date:  2003 Sep-Oct       Impact factor: 3.481

View more
  34 in total

1.  Impaired mitochondrial function in human placenta with increased maternal adiposity.

Authors:  James Mele; Sribalasubashini Muralimanoharan; Alina Maloyan; Leslie Myatt
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-07-15       Impact factor: 4.310

2.  Maternal obesity alters brain derived neurotrophic factor (BDNF) signaling in the placenta in a sexually dimorphic manner.

Authors:  Calais S Prince; Alina Maloyan; Leslie Myatt
Journal:  Placenta       Date:  2016-11-24       Impact factor: 3.481

3.  Differential sex-specific effects of oxygen toxicity in human umbilical vein endothelial cells.

Authors:  Yuhao Zhang; Krithika Lingappan
Journal:  Biochem Biophys Res Commun       Date:  2017-03-16       Impact factor: 3.575

4.  Melatonin Improves Mitochondrial Respiration in Syncytiotrophoblasts From Placentas of Obese Women.

Authors:  Kayla E Ireland; Alina Maloyan; Leslie Myatt
Journal:  Reprod Sci       Date:  2017-04-26       Impact factor: 3.060

5.  Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment.

Authors:  Stefanie L Bronson; Tracy L Bale
Journal:  Endocrinology       Date:  2014-05-05       Impact factor: 4.736

6.  Gestational differences in murine placenta: Glycolytic metabolism and pregnancy parameters.

Authors:  Renee E Albers; Christopher A Waker; Chanel Keoni; Melissa R Kaufman; Michael A Bottomley; Sarah Min; David R Natale; Thomas L Brown
Journal:  Theriogenology       Date:  2017-11-04       Impact factor: 2.740

7.  A role for microRNAs in the epigenetic control of sexually dimorphic gene expression in the human placenta.

Authors:  Lauren Eaves; Preeyaphan Phookphan; Julia Rager; Jacqueline Bangma; Hudson P Santos; Lisa Smeester; Thomas Michael O'Shea; Rebecca Fry
Journal:  Epigenomics       Date:  2020-09-09       Impact factor: 4.778

8.  Maternal choline supplementation during murine pregnancy modulates placental markers of inflammation, apoptosis and vascularization in a fetal sex-dependent manner.

Authors:  Sze Ting Cecilia Kwan; Julia H King; Jian Yan; Xinyin Jiang; Emily Wei; Vladislav G Fomin; Mark S Roberson; Marie A Caudill
Journal:  Placenta       Date:  2017-03-30       Impact factor: 3.481

9.  The impact of female fetal sex on preeclampsia and the maternal immune milieu.

Authors:  Brandie D Taylor; Roberta B Ness; Mark A Klebanoff; Gong Tang; James M Roberts; David M Hougaard; Kristin Skogstrand; Catherine L Haggerty
Journal:  Pregnancy Hypertens       Date:  2018-02-24       Impact factor: 2.899

10.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.